Totalip 10 mg x 100 Tablets

Indications

Hypercholesterolemia

Primary hypercholesterolaemia, including familial hypercholesterolaemia (heterozygous variant) or mixed hyperlipidemia (corresponding to types IIa and IIb of the Fredrickson classification) when the response to diet and other non-pharmacological measures is insufficient

Homozygous familial hypercholesterolaemia, as an adjunct to other lipid-lowering therapies (eg LDL-apheresis) or when such therapies are not available

Prevention of cardiovascular disease

Prevention of cardiovascular events in patients considered to be at high risk of having a first cardiovascular event, in addition to the correction of other risk factors